PREVENTION OF COMPLICATIONS AFTER TRANSRECTAL PROSTATE BIOPSY
- Authors: Gevorkyan A.1, Avakyan A.1
-
Affiliations:
- Polyclinic One Hundred and Ninety-Five, West Administrative District, Moscow
- Issue: Vol 24, No 6 (2013)
- Pages: 69-71
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115718
- ID: 115718
Cite item
Abstract
The rate of infectious complications after transrectal prostate cancer in the Urology Unit of Polyclinic One Hundred and Ninety-Five (West Administrative District, Moscow) in 2009-2011 is analyzed by the results of biopsy specimen inoculation for pathogenic flora and those of postbiopsy antibiotic sensitivity determination.
Full Text
About the authors
A. Gevorkyan
Polyclinic One Hundred and Ninety-Five, West Administrative District, Moscow
Email: armmed1@mail.ru
Candidate of Medical Sciences
A. Avakyan
Polyclinic One Hundred and Ninety-Five, West Administrative District, Moscow
References
- Boyle P., Ferlay J. Cancer incidence and mortality in Europe 2004 // Ann. Oncol. - 2005; 16 (3): 481-8.
- Jemal A., Siegel R., Ward E. et al. Cancer statistics, 2008 // CA Cancer J. Clin. - 2008; 58 (2): 71-96.
- Чиссов В.И., Старинский В.В. Ход реализации мероприятий по совершенствованию онкологической помощи населению России. МНИОИ им. П.А. Герцена // Рос. онкол. журн. - 2011; 4.
- Велиев Е.И., Богданов А.Б. Формирование показаний к первичной и повторной трансректальной мультифокальной биопсии предстательной железы и вероятные осложнения // Урология сегодня. - 2010; 1.
- Webb N., Woo H. Antibiotic prophylaxis for prostate biopsy // BJU Int. -2002; 89: 824-8.
- Nobrega de Jesus C., Correa L., Padovani C. Complications and risk factors in transrectal ultrasound-guided prostate biopsies // San Paulo Med. J. - 2006; 124 (4): 198-202.
- Miura T., Tanaka K., Shigemura K. et al. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: Report of four cases and review of the literature // Int. J.Urol. - 2008; 15: 457-9.
- Scotton P., Vaglia A., Rizzi M. et al. Which antibiotic prophylaxis to use for urologic procedures in patients at risk for infective endocarditis: a report on two cases // Infez. Med. - 2006; 14 (4): 246-7.
- Crundwell M., Cooke P., Wallace D. Patients’ tolerance of transrectal ultrasound-guided prostatic biopsy: an audit of 104 cases // BJU Int. - 1999; 83: 792-5.
- Puig J., Darnell A., Bermudez P. et al. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary? // Eur. Radiol. - 2006; 16: 939-43.
- Aron M., Rajeev T.P, Gupta N.P. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study // BJU Int. - 2000; 85: 682-5.
- Kapoor D., Klimberg I., Malek G. et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy // Urology. - 1998; 52: 552-8.
- Зайцев А.В., Пушкарь Д.Ю., Раснер П.И. и др. Антибактериальная профилактика при трансректальной биопсии предстательной железы // РМЖ. -2009; 17 (14): 910-3.
- Shandera K., Thibault G., Deshon G. Jr. Variability in patient preparation for prostate biopsy among American urologists // Urology. - 1998; 52: 644-6.
- Burden H., Ranasinghe W., Persad R. Antibiotics for transrectal ultrasonography-guided prostate biopsy: are we practicing evidence-based medicine? BJU Int. - 2008; 101: 1202-4.
- Schaeffer A., Montorsi F., Scattoni V. et al. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate // BJU Int. - 2007; 100: 51-7.
- Briffaux R., Coloby P., Bruyere F. et al. One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy // BJU Int. - 2008; 103: 1069-73.
- Тal R., Livne P., Lask D. et al. Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy // J. Urol. -2003; 169: 1762-5.
- Drusano G., Preston S., Van Guilder M. et al. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin // Antimicrob. Agents Chemother. - 2000; 44 (8): 2046-51.
- Croom K., Goa K.L. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States // Drugs. - 2003; 63 (24): 2768-802.
- Naber K. Levofloxacin in the treatment of urinary tract infection and prostatitis // J. Chemother. - 2004; 16 (2): 18-21.
- Griffith B., Morey A., Ali-Khan M. et al. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk // J. Urol. - 2002; 168 (3): 1021-3.
- Shigehara K., Miyagi T., Nakashima T. et al. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis // J. Infect. Chemother. - 2008; 14 (1): 40-3. Epub. Feb. 24 2008.